2017-06-14 | Immunic, Inc. IMUX | General Counsel and Secretary | 5,000 0.0118% | $3.09 | $15,449 | +75.81% | ||
2015-10-26 | Immunic, Inc. IMUX | General Counsel and Secretary | 4,000 0.0135% | $7.00 | $28,000 | +12.02% | ||
2015-10-23 | Immunic, Inc. IMUX | General Counsel and Secretary | 14,770 0.0509% | $6.76 | $99,866 | +18.34% | ||
2009-02-19 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 3,208 0.0011% | $50.90 | $163,301 | -2.66% | |
2009-02-11 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 2,258 0.0008% | $50.81 | $114,729 | -3.19% | |
2008-07-22 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 6,485 0.0014% | $43.50 | $282,098 | -31.83% | |
2008-07-21 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 6,485 0.0014% | $43.50 | $282,098 | -27.26% | |
2008-04-14 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 3,212 0.0011% | $64.25 | $206,366 | -21.01% | |
2008-02-12 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 2,267 0.0008% | $61.14 | $138,597 | -12.9% | |
2007-07-25 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 20,000 0.0051% | $43.50 | $870,000 | +5.61% | |
2007-06-27 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 15,352 0.003% | $35.37 | $543,000 | +15.2% | |
2007-04-23 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 18,760 0.0055% | $48.90 | $917,364 | +22.78% | |
2007-04-20 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 7,519 0.0022% | $46.03 | $346,073 | +28.58% | |
2007-02-13 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 2,334 0.0007% | $49.22 | $114,870 | +15.8% | |
2006-11-15 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 7,850 0.0017% | $35.37 | $277,655 | +5.15% | |
2006-10-31 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 23,004 0.0067% | $46.77 | $1.08M | +7.27% | |
2004-12-09 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 5,000 0.0008% | $35.37 | $176,850 | -40.29% | |
2004-11-08 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 571 0.0002% | $62.00 | $35,402 | -34.64% | |
2004-05-18 | Sale | Biogen Inc. BIIB | EVP, New Ventures | 15,000 0.0044% | $59.05 | $885,800 | +0.76% |